Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for Chronic Refractory Breathlessness in COPD
NCT02455362Phase 3Withdrawn
- Sponsor
- Flinders University
- Start
- May 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of morphine hydrochloride in chronic obstructive pulmonary disease (COPD), sponsored by Flinders University. Planned start May 2015; status: withdrawn.
02
Drugs
morphine hydrochloride
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02455362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455362.